Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Finance Home
Watchlists
My Portfolio
Markets
News
Videos
Yahoo Finance Plus
Screeners
Personal Finance
Crypto
Industries
Contact Us
Advertisement
Advertisement
U.S. markets closed
S&P 500
4,299.70
+25.19
(+0.59%)
Dow 30
33,666.34
+116.07
(+0.35%)
Nasdaq
13,201.28
+108.43
(+0.83%)
Russell 2000
1,794.31
+15.41
(+0.87%)
Crude Oil
91.81
-1.87
(-2.00%)
Gold
1,881.70
-9.20
(-0.49%)
Advertisement
Advertisement
Advertisement
Advertisement
Cara Therapeutics, Inc. (CARA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
Visitors trend
2W
10W
9M
1.6900
+0.0100
(+0.60%)
At close: 04:00PM EDT
1.6899
-0.00
(-0.01%)
After hours:
05:30PM EDT
Advertisement
Summary
Company Insights
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Subscribe to Yahoo Finance Plus Essential to download historical data
Download
Income Statement
Expand All
All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Learn more
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
27,172
41,867
23,028
135,082
19,886
Cost of Revenue
9,193
7,266
-
-
-
Gross Profit
17,979
34,601
-
-
-
Operating Expense
133,121
122,136
112,111
129,697
131,565
Operating Income
-115,142
-87,535
-89,083
5,385
-111,679
Other Income Expense
3,479
2,061
642
2,334
4,490
Pretax Income
-111,663
-85,474
-88,441
7,719
-107,189
Tax Provision
-
0
0
-691
-816
Net Income Common Stockholders
-111,663
-85,474
-88,441
8,410
-106,373
Diluted NI Available to Com Stockholders
-111,663
-85,474
-88,441
8,410
-106,373
Basic EPS
-
-1.59
-1.74
0.18
-2.49
Diluted EPS
-
-1.59
-1.74
0.18
-2.49
Basic Average Shares
-
53,654
50,719
47,413
42,669
Diluted Average Shares
-
53,654
50,719
47,915
42,669
Total Operating Income as Reported
-115,142
-87,535
-89,083
5,385
-111,679
Total Expenses
142,314
129,402
112,111
129,697
131,565
Net Income from Continuing & Discontinued Operation
-111,663
-85,474
-88,441
8,410
-106,373
Normalized Income
-111,663
-85,474
-88,441
8,410
-106,373
EBIT
-115,142
-87,535
-89,083
5,385
-111,679
EBITDA
-114,902
-87,535
-89,083
5,594
-111,679
Reconciled Cost of Revenue
9,078
7,266
-
-
-
Reconciled Depreciation
240
248
248
209
198
Net Income from Continuing Operation Net Minority Interest
-111,663
-85,474
-88,441
8,410
-106,373
Normalized EBITDA
-114,902
-87,535
-89,083
5,594
-111,679
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Yahoo Finance Plus Essential access required.
Learn more
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your Privacy Choices
About Our Ads
Sitemap